Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group - Rastogi, P; Buyse, M E; Swain, S M (Clin Breast Cancer, 2011)
et al.